Let's not forget tautomers

Journal of Computer-Aided Molecular Design

Volumn 23, Issue 10, 2009, Pages 693-704

  Martin, Yvonne Connolly ^a  

^a Martin Consulting   (United States)

Author keywords

Drug design; Hydrophobicity Protein recognition; Tautomer

Indexed keywords

COMPUTATIONAL CHEMISTRY; HYDROPHOBICITY; PROTEINS;

3-D SHAPE; DRUG DESIGN; HYDROPHOBICITY PROTEIN RECOGNITION; INTRAMOLECULAR MOVEMENT; LIBRARY DESIGNS; MOLECULAR FINGERPRINT; PROTEIN RECOGNITION; SHAPE PROPERTY; TAUTOMER; TAUTOMERIC RATIO;

MOLECULES;

BINDING AFFINITY; CHEMICAL BINDING; CHEMICAL REACTION; CHEMICAL STRUCTURE; COMPUTER AIDED DESIGN; COMPUTER PROGRAM; CRYSTAL STRUCTURE; HYDROPHOBICITY; MOLECULAR DOCKING; MOLECULAR INTERACTION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; SOLVENT EFFECT; STRUCTURE ANALYSIS; TAUTOMER; ARTICLE; DRUG DESIGN;

DRUG DESIGN; MOLECULAR STRUCTURE; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 76249106208     PISSN: 0920654X     EISSN: 15734951     Source Type: Journal    
DOI: 10.1007/s10822-009-9303-2     Document Type: Review

References (75)

1. Pospisil P, Ballmer P, Scapozza L, Folkers G (2003) J Recept Signal Transduct 23:361-371
2. Masek BB, Clark RD, Yu Y, Smith K, Pearlman RS (2005) Hi fidelity chemistry. Tripos, Inc. http://www.bagim.org/presentation-files/06-03-15-Brian- Masek/HiFi-Chemistry.pdf. Accessed 3 Jan 2009
3. Oellien F, Cramer J, Beyer C, Ihlenfeldt W-D, Selzer PM (2006) J Chem Inf Model 46:2342-2354
4. Subramaniam S, Mchrotra M, Gupta D (2008) Bioinformation 3:14-17
5. Milletti F, Stochi L, Sforna G, Cross S, Cruciani G (2009) J Chem Inf Model 49:68-75
6. Todorov NP, Monthoux PH, Alberts IL (2009) J Chem Inf Model 46:1134-1142
7. Elguero J, Marzin C, Katritzky A, Linda P (1976) Advances in heterocyclic chemistry. Supplement 1: the tautomerism of het-erocycles. Academic Press, New York
8. Shcherbakova I, Elguero J, Katritzky AR (2000) Adv Heterocycl Chem 77:51-113
9. Katritzky A (1994) Lecture 6. Heterocyclic tautomerism. http://ufark12.chem.ufl.edu/Lectures/L6.pdf. Accessed 15 April 2009
10. McConnell JF, Sharma BD, Marsh RE (1964) Nature 203:399-400
11. Steiner T, Koellner G (1997) Chem Commun 1997:1207-1208
12. Kubicki M (2004) Acta Crystallogr B 60:191-196
13. Wu Z-H, Ma J-P, Wu X-W, Huang R-Q, Dong Y-B (2009) Acta Crystallogr Sect C Cryst Struct Commun 65:o128-o130
14. Elgureo J, Marzin C, Katritzky AR, Linda P (1976) Advances in heterocyclic chemistry supplement 1: the tautomerism of het-erocycles. Academic Press, New York, pp 302-303
15. Porter WR Tautomers of warfarin. Personal communication. August 2009
16. Finkelstein J, Williams T, Toome V, Traiman S (1976) J Org Chem 32:3229-3230
17. Brandstetter H, Grams F, Glitz D, Lang A, Huber R, Bode W, Krell H-W, Engh RA (2001) J Biol Chem 276:17405-17412
18. Senthilkumar K, Kolandaivel P (2002) J Comput-Aided Mol Des 16:263-272
19. Yan XJ, Day P, Hollis T, Monzingo AF, Schelp E, Robertus JD, Milne GWA, Wang SM (1998) Proteins Struct Funct Genet 31:33-41
20. Furet P, Meyer T, Strauss A, Raccuglia S, Rondeau J-M (2002) Bioorg Med Chem Lett 12:221-224
21. Dinges J, Ashworth KL, Akritopolou-Zanze I, Arnold LD, Bau-meister SA, Bousquet PF, Cunha GA, Davidsen SK, Djuric SW, Gracias VJ, Michaelides MR, Rafferty P, Sowin TJ, Stewart KD, Xia Z, Zhang HQ (2006) Bioorg Med Chem Lett 16:4266-4271
22. Ho CY, Ludovici DW, Maharoof USM, Mei J, Sechler JL, Tu-man RW, Strobel ED, Andraka L, Yen H-K, Leo G, Li J, Almond H, Lu H, DeVine A, Tominovich RM, Baker J, Emanuel S, Gruninger RH, Middleton SA, Johnson DL, Galemmo RA Jr (2005) J Med Chem 48:8163-8173
23. Taylor AB, Johnson WH, Czerwinski RM, Li H-S, Hackert ML, Whitman CP (1999) Biochemistry 38:7444-7452
24. Temperini C, Cecchi A, Scozzafava A, Supuran CT (2009) Bioorg Med Chem 17:1214-1221
25. Garcia-Viloca M, AlHambra C, Truhlar DG, Jiali G (2003) J Comput Chem 24:177-190
26. Fenn TD, Ringe D, Petsko GA (2004) Biochemistry 43:6464-6474
27. Rozwarski DA, Grant GA, Barton DHR, Jacobs WRJ Jr, Sacchettini JC (1998) Science 279:98-102
28. Delaine T, Bernardes-Genisson V, Stigliani J-L, Gornitzka H, Meunier B, Bernadou J (2007) Eur J Org Chem 2007:1624-1630
29. Stigliani J-L, Arnaud P, Delaine T, Bernardes-Génisson V, Meunier B, Bernadou J (2008) J Mol Graphics Modell 27:536-545
30. Dupradeau FY, Case DA, Yu C, Jimenez R, Romesberg FE (2005) J Am Chem Soc 127:15612-15617
31. Pilot P (2008) Scitegic chemistry components Accelrys. http://accelrys.com/products/datasheets/chemistry-component-collection. pdf. Accessed 4 May 2008
32. Proudfoot JR (2005) Bioorg Med Chem Lett 15:1087-1090
33. Jang YH, Goddard WA III, Noyes KT, Sowers LC, Hwang S, Chung DS (2002) Chem Res Toxicol 15:1023-1035
34. Duarte HA, Carvalho S, Paniago EB, Simas AM (1999) J Pharm Sci 88:111-120
35. Lee AC, Crippen GM (2009) J Chem Inf Model
36. Szegezdi J, Csizmadia F (2007) Tautomer generation. pKa based dominance conditions for generating dominant tautomers. American Chemical Society Fall meeting, Aug 19-23, 2007. http://www.chemaxon.com/conf/Tautomer-generation-A4. pdf. Accessed 30 April 2009
37. Worth GA, Richards WG (1994) J Am Chem Soc 116:239-250
38. Rashin AA, Rabinowitz JR, Banfelder JR (1990) J Am Chem Soc 112:4133-4137
39. Kleinpeter E, Thomas S, Fischer G (1995) J Mol Struct 355:273-285
40. Cramer CJ, Truhlar DG (1996) In: Mezey PG, Tapia O, Bertrán J (eds) Solvent effects and chemical reactivity. Springer, Dortrecht, pp 1-80
41. Karelson M, Maran U, Katritzky AR (1996) Tetrahedron 52:11325-11328
42. Koskinen JT, Koskinen M, Mutikainen I, Mannfors B, Elo H (1996) Z Naturforsch A Phys Sci 511771-1778
43. Maran U, Karelson M, Katritzky AR (1996) Int J Quantum Chem 60:41-49
44. Maran U, Karelson M, Katritzky AR (1996) Int J Quantum Chem 601765-1773
45. Danilov VI, Stewart JJP, Les A, Alderferd JL (2000) Chem Phys Lett 328:75-82
46. Rogstad KN, Jang YH, Sowers LC, Goddard WA III (2003) Chem Res Toxicol 161455-1462
47. Godsi O, Turner B, Suwinska K, Peskin U, Eichen Y (2004) J Am Chem Soc 12613519-13525
48. Podolyan Y, Gorb L, Leszczynski J (2005) J Phys Chem A 10910445-10450
49. Martin YC (2007) We can't predict log P, so why should we expect to predict affinity? Open eye. http://eyesopen.com/about/events/cup8/martin-yvonne/ Y.Martin-CUPVIII.pdf. Accessed 27 July 2009
50. Machatha S, Yalkowsky S (2005) Comparison of the octanol-water partition coefficients calculated by CLOGP, ACDLOGP and KowWin to experimentally determined values. http://www.aapsj.org/abstracts/AM-2005/AAPS2005-000448.pdf. Accessed 15 April 2009
51. Meylan WM, Howard PH, Boethling RS (1996) Environ Toxicol Chem 15:100-106
52. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Adv Drug Deliv Rev 23:3-25
53. Sanghvi T, Jain N, Yang G, Yalkowsky SH (2003) QSAR Comb Sci 22:258-262
54. Clark DE (1999) J Pharm Sci 88:815-821
55. Sayle R, Delaney J (1999) Canonicalization and enumeration of tautomers. http://www.daylight.com/meetings/emug99/Delany/taut-html/sld001.htm. Accessed 31 August 2009
56. Kenny PW, Sadowski J (2005) In: Oprea T (ed) Chemoinfor- matics in drug discovery. Wiley-VCH Verlag GmbH & Co, Weinheim, pp 271-285
57. Dittmar PG, Stobaugh RE, Watson CE (1976) J Chem Inf Comput Sci 16:111-121
58. (2009) Pubchem. National Institutes of Health. http://pubchem.ncbi.nlm. nih.gov/. Accessed 25 July 2009
59. (2009) Chemspider. http://www.chemspider.com/. Accessed 25 July 2009
60. Muchmore SW, Debe DA, Metz JT, Brown SP, Martin YC, Hajduk PJ (2008) J Chem Inf Model 48:941-948
61. Hansch C, Leo A (1995) Exploring QSAR: fundamentals and applications in chemistry and biology. American Chemical Society, Washington DC
62. Martin YC, Hackbarth JJ (1976) J Med Chem 191033-1039
63. Rastelli G, Thomas B, Kollman PA, Santi DV (1995) J Am Chem Soc 1177213-7227
64. Perakyla M, Kollman PA (1997) J Am Chem Soc 1191189-1196
65. Alex A, Finn P (1997) J Mol Struct 398:551-554
66. Hart JC, Burton NA, Hillier IH, Harrison MJ, Jewsbury P (1997) Chem Commun 1431-1432
67. Wang W, Donini O, Reyes CM, Kollman PA (2001) Annu Rev Biophys Biomol Struct 30:211-243
68. Khandelwal A, Lukacova V, Kroll DM, Comez D, Raha S, Balaz S (2004) QSAR Comb Sci 23:754-766
69. Riccardi D, Schaefer P, Cui Q (2005) The Journal of Physical Chemistry B 10917715-17733
70. Gilson MK, Zhou H-X (2007) Annu Rev Biophys Biomol Struct 36:21-42
71. Baldwin JE (1976) J Chem Soc Chem Commun (18):734-736
72. Stewart J (1997) J Mol Struct 401:195-205
73. Stewart JJP (2001) Mopac 2002 manual. Fujitsu Ltd. http://www.cache. fujitsu.com/mopac/Mopac2002manual/index.html. Accessed 27 July 2009
74. Leo A, Hoekman D (2000) Perspect Drug Discovery Des 19-38
75. Meylan WM, Howard PH (2000) Perspect Drug Discovery Des 19:67-84